LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Etoposide | 0.1 | 91.27 | 84.90 | 1 | 7420 | 0.0001 | -0.4977 | MN20160318_Q02 | E05 |
MCF 10A-H2B-mCherry | 0 | 91.27 | 84.90 | 4564 | 7420 | 0.6151 | 0.8548 | MN20160318_Q02 | K09 | |
MCF 10A-H2B-mCherry | Etoposide | 0.018333 | 91.27 | 84.90 | 6911 | 7420 | 0.9314 | 0.9781 | MN20160318_Q02 | M07 |
MCF 10A-H2B-mCherry | 0 | 91.27 | 84.90 | 12270 | 7420 | 1.6536 | 1.1622 | MN20160318_Q02 | I06 | |
MCF 10A-H2B-mCherry | Etoposide | 0.1 | 91.27 | 84.90 | 619 | 7420 | 0.0834 | 0.3607 | MN20160318_Q02 | I13 |
MCF 10A-H2B-mCherry | 0 | 91.27 | 84.90 | 4011 | 7420 | 0.5406 | 0.8181 | MN20160318_Q02 | L08 | |
MCF 10A-H2B-mCherry | Etoposide | 0.056667 | 91.27 | 84.90 | 535 | 7420 | 0.0721 | 0.3303 | MN20160318_Q02 | H04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 91.27 | 84.90 | 194 | 7420 | 0.0261 | 0.1367 | MN20160318_Q02 | E17 |
MCF 10A-H2B-mCherry | Etoposide | 0.018333 | 91.27 | 84.90 | 8571 | 7420 | 1.1551 | 1.0452 | MN20160318_Q02 | J08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 91.27 | 84.90 | 805 | 7420 | 0.1085 | 0.4173 | MN20160318_Q02 | I11 |
MCF 10A-H2B-mCherry | Etoposide | 0.018333 | 91.27 | 84.90 | 13170 | 7420 | 1.7749 | 1.1861 | MN20160318_Q02 | J08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 91.27 | 84.90 | 5 | 7420 | 0.0007 | -0.3554 | MN20160318_Q02 | E06 |
MCF 10A-H2B-mCherry | Etoposide | 0.056667 | 91.27 | 84.90 | 7589 | 7420 | 1.0228 | 1.0070 | MN20160318_Q02 | H04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 91.27 | 84.90 | 1 | 7420 | 0.0001 | -0.4977 | MN20160318_Q02 | I11 |
MCF 10A-H2B-mCherry | Etoposide | 0.1 | 91.27 | 84.90 | 11706 | 7420 | 1.5776 | 1.1465 | MN20160318_Q02 | I13 |
MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 91.27 | 84.90 | 678 | 7420 | 0.0914 | 0.3801 | MN20160318_Q02 | I17 |
MCF 10A-H2B-mCherry | Etoposide | 0.056667 | 91.27 | 84.90 | 11278 | 7420 | 1.5199 | 1.1341 | MN20160318_Q02 | F14 |
MCF 10A-H2B-mCherry | 0 | 91.27 | 84.90 | 3269 | 7420 | 0.4406 | 0.7613 | MN20160318_Q02 | I06 | |
MCF 10A-H2B-mCherry | Etoposide | 0.056667 | 91.27 | 84.90 | 602 | 7420 | 0.0811 | 0.3549 | MN20160318_Q02 | F14 |
MCF 10A-H2B-mCherry | Alpelisib | 0.31623 | 91.27 | 84.90 | 10699 | 7420 | 1.4419 | 1.1168 | MN20160318_Q02 | D11 |
MCF 10A-H2B-mCherry | Etoposide | 0.1 | 91.27 | 84.90 | 1 | 7420 | 0.0001 | -0.4977 | MN20160318_Q02 | E05 |
MCF 10A-H2B-mCherry | 0 | 91.27 | 84.90 | 6122 | 7420 | 0.8251 | 0.9413 | MN20160318_Q02 | H10 | |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 91.27 | 84.90 | 1382 | 7420 | 0.1863 | 0.5412 | MN20160318_Q02 | D15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 91.27 | 84.90 | 789 | 7420 | 0.1063 | 0.4129 | MN20160318_Q02 | F15 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 91.27 | 84.90 | 11152 | 7420 | 1.5029 | 1.1304 | MN20160318_Q02 | D15 |